These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 1354573)
21. Short-term cardiovascular effects of somatostatin in patients with cirrhosis. Gaudin C; Moreau R; Champigneulle B; Soubrane O; Kleber G; Lebrec D Liver; 1995 Oct; 15(5):236-41. PubMed ID: 8531592 [TBL] [Abstract][Full Text] [Related]
22. Effect of somatostatin on liver blood flow and liver metabolic activity in patients with cirrhosis. Merkel C; Gatta A; Caregaro L; Sacerdoti D; Rondana M; Ruol A Scand J Clin Lab Invest; 1987 Nov; 47(7):667-72. PubMed ID: 2891182 [TBL] [Abstract][Full Text] [Related]
23. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: comparison with vasopressin. Bosch J; Kravetz D; Rodes J Gastroenterology; 1981 Mar; 80(3):518-25. PubMed ID: 6108897 [TBL] [Abstract][Full Text] [Related]
24. Lack of effects of nifedipine on hepatic hemodynamics in patients with HBsAg-positive cirrhosis. Lay CS; Tsai YT; Kong CW; Lee FY; Lee SD; Lo KJ; Chiang BN; Chen KY Liver; 1987 Aug; 7(4):223-7. PubMed ID: 3683094 [TBL] [Abstract][Full Text] [Related]
25. [Effects of two different dosages of octreotide on portal pressure and hepatic hemodynamics in cirrhotic portal hypertensive patients after portal-azygous devascularization and splenectomy]. Lu SC; Meng FK; Ding HG; Zhang JG; Ding L; Wang SZ Zhonghua Nei Ke Za Zhi; 2007 Apr; 46(4):290-3. PubMed ID: 17637266 [TBL] [Abstract][Full Text] [Related]
26. Effects of somatostatin, terlipressin and somatostatin plus terlipressin on portal and systemic hemodynamics and renal sodium excretion in patients with cirrhosis. Kalambokis G; Economou M; Paraskevi K; Konstantinos P; Pappas C; Katsaraki A; Tsianos EV J Gastroenterol Hepatol; 2005 Jul; 20(7):1075-81. PubMed ID: 15955217 [TBL] [Abstract][Full Text] [Related]
27. Effects of terlipressin and somatostatin on liver and thorax blood volumes in patients with cirrhosis. Kalambokis G; Tsiouris S; Tsianos EV; Baltayiannis G; Pakou B; Fotopoulos A Liver Int; 2010 Oct; 30(9):1371-8. PubMed ID: 20738780 [TBL] [Abstract][Full Text] [Related]
28. Assessment of hepatic blood flow using continuous infusion of high clearance drugs. Schoemaker RC; Burggraaf J; Cohen AF Br J Clin Pharmacol; 1998 May; 45(5):463-9. PubMed ID: 9643619 [TBL] [Abstract][Full Text] [Related]
29. Effects of verapamil on estimated hepatic blood flow in patients with HBsAg-positive cirrhosis. Lay CS; Tsai YT; Kong CW; Lee FY; Lee SD; Chen KY; Chiang BN; Lo KJ Hepatogastroenterology; 1988 Jun; 35(3):121-4. PubMed ID: 3402902 [TBL] [Abstract][Full Text] [Related]
30. Validation of color Doppler EUS for azygos blood flow measurement in patients with cirrhosis: application to the acute hemodynamic effects of somatostatin, octreotide, or placebo. Nishida H; Giostra E; Spahr L; Mentha G; Mitamura K; Hadengue A Gastrointest Endosc; 2001 Jul; 54(1):24-30. PubMed ID: 11427837 [TBL] [Abstract][Full Text] [Related]
31. Effects of somatostatin, octreotide and pitressin plus nitroglycerine on systemic and portal haemodynamics in the control of acute variceal bleeding. Zhang HB; Wong BC; Zhou XM; Guo XG; Zhao SJ; Wang JH; Wu KC; Ding J; Lam SK; Fan DM Int J Clin Pract; 2002; 56(6):447-51. PubMed ID: 12166543 [TBL] [Abstract][Full Text] [Related]
32. Effect of somatostatin on splanchnic hemodynamics in patients with liver cirrhosis and portal hypertension. Merkel C; Gatta A; Zuin R; Finucci GF; Nosadini R; Ruol A Digestion; 1985; 32(2):92-8. PubMed ID: 2864299 [TBL] [Abstract][Full Text] [Related]
33. Effects of glucose on hepatic conversion of aminonitrogen to urea in patients with cirrhosis: relationship to glucagon. Hamberg O; Vilstrup H Hepatology; 1994 Jan; 19(1):45-54. PubMed ID: 7903954 [TBL] [Abstract][Full Text] [Related]
34. Drug disposition in patients with HBsAg-positive chronic liver disease. Villeneuve JP; Thibeault MJ; Ampelas M; Fortunet-Fouin H; LaMarre L; Côté J; Pomier-Layrargues G; Huet PM Dig Dis Sci; 1987 Jul; 32(7):710-4. PubMed ID: 3595383 [TBL] [Abstract][Full Text] [Related]
35. Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study. Kouroumalis E; Skordilis P; Thermos K; Vasilaki A; Moschandrea J; Manousos ON Gut; 1998 Mar; 42(3):442-7. PubMed ID: 9577356 [TBL] [Abstract][Full Text] [Related]
36. Effect of somatostatin on splanchnic hemodynamics in patients with cirrhosis of the liver and in normal subjects. Sonnenberg GE; Keller U; Perruchoud A; Burckhardt D; Gyr K Gastroenterology; 1981 Mar; 80(3):526-32. PubMed ID: 6108898 [TBL] [Abstract][Full Text] [Related]
37. [Effect of somatostatin on splanchnic hemodynamics in liver cirrhosis]. Merkel C; Gatta A; Zuin R; Finucci GF; Arnaboldi L; Ruol A Minerva Med; 1984 Nov; 75(44):2673-8. PubMed ID: 6151151 [TBL] [Abstract][Full Text] [Related]